Ask AI

Official Conference Coverage of AIDS 2026: The Latest Updates in HIV *

This program outlines important data and summarizes highlights from the 26th International AIDS Conference (AIDS 2026).

Share

Program Content

15 Capsule Summaries

Activities

ISLEND 1 Switch to ISL LEN
ISLEND-1: Switch From BIC/FTC/TAF to Once-Weekly ISL/LEN in People With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2026

ISLEND 2 Switch to ISL LEN
ISLEND-2: Switch From Standard-of-Care to Once-Weekly ISL/LEN in People With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 30, 2026

Efficacy of DOR ISL With Baseline RAMs
Efficacy of Switch to DOR/ISL With Baseline RAMs: Retrospective Analysis of 3 Phase III Trials
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

Phase IIb MK 8591B 060
Phase IIb MK-8591B-060: Switch to Once-Weekly Islatravir + Ulonivirine in Adults With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

PURPOSE 1 OLE
PURPOSE 1 OLE: Twice-Yearly LEN PrEP in Adolescent Cisgender Women
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

BICSTaR Switch to BIC FTC TAF
BICSTaR: Real-world Switch to BIC/FTC/TAF in Treatment-Experienced People Living With HIV and Detectable HIV-1 RNA
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

Twice Yearly LEN TAB ZAB
Phase II Study of Twice-Yearly LEN + TAB + ZAB in People Living With Virologically Suppressed HIV: Wk 104 Results
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

PrIMO
PrIMO: Prospective Cohort Study Evaluating the Safety of LA CAB vs Oral PrEP During Pregnancy in Malawi
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2026

VOGUE
VOGUE: DTG/3TC vs BIC/FTC/TAF as Initial ART for People Living With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2026

LATA Adolescent LA CAB RPV
LATA: Switch to LA CAB + RPV vs DTG/3TC/TDF in Adolescents Living With HIV 
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2026

PURPOSE 2 OLE
PURPOSE 2 OLE: Twice-Yearly LEN PrEP in Men and Gender-Diverse Individuals
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2026

LA CAB PrEP Discordant HIV Test
ImPrEP CAB Brasil: Early Detection of HIV With LA CAB PrEP 
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2026

MK 8591A 053
MK-8591A-053: Subgroup Analysis of DOR/ISL vs BIC/FTC/TAF in Treatment-Naive People Living With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2026

LA CAB PrEP in Women
Real-world Experience With LA CAB PrEP in Women: US OPERA Cohort 
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2026

MK 8591A 051 Post Hoc Analysis
MK-8591A-051 Post Hoc Analysis: Switch From Complex ART to DOR/ISL in People Living With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with the International AIDS Society

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

International AIDS Society

ProCE Banner

*Decera Clinical Education is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.